@mobitz

Nashville Interventional Cardiologist

 Nashville, TN
bit.ly/1N51jVO
Joined May 2009
  • Tweets5.1K
  • Following1.5K
  • Followers2.3K
199Media
Influence of Chronic Kidney Disease on Outcomes Following Paclitaxel-Coated Balloon Angioplasty for Coronary In-Stent Restenosis. An AGENT IDE Subgroup Analysis. CKD did not influence outcome @rwyeh @ajaykirtane @mobitz @bigboy1202 @behnam_tehrani ahajrnls.org/4roRGvc
1
2
5
1,081
EVERY state needs this! And every hospital needs to follow their lead. 👇 👏👏👏
Rich Duszak, MD
@RichDuszakAug 20
Important development in the national @ABMSCert MOC discussion: the Florida Board of Medicine has approved @nbpasadvocacy as a recognizing agency: "Once the final order is issued, physicians who hold qualifying NBPAS certification will be permitted to identify and advertise themselves as board certified in Florida." flmedical.org/florida/Florid… @FloridaMedical
5
22
1
90
13,506
BJefferson retweeted
SCAI
@SCAIAug 14
📹 New data, expert perspectives, practical insights. Explore emerging #IVL technologies with authors from the RESTORE ATK and FRACTURE IDE studies and an expert panel discussing recent peripheral and coronary data, calcium assessment, lesion preparation, and implications for clinical practice. Watch the conversation ▶️ youtu.be/yzzvzfr9bjE?si=rtsT… #InterventionalCardiology @EricSecemskyMD @BinitaShahMD @sahilparikhmd @mobitz

New and Emerging IVL: Recent Peripheral and Coronary Data from...

Coronary artery calcification complicates PCI by limiting stent del...

youtube.com
1
5
2,171
BJefferson retweeted
CircInterventions@CircIntvAug 6
Post-treatment in-lesion % diameter stenosis was the key modifiable predictor of TLF for in-stent restenosis treated with paclitaxel-coated balloon. Predictors of drug coated ballon restenosis. Insights from the AGENT IDE Trial @rwyeh @mobitz @JDawnAbbott1 ahajrnls.org/4wb62zO
2
16
1
27
2,353
Brilliant exposé on ABMS lobbying tactics used to maintain their MOC monopoly and mislead the public medicaleconomics.com/view/ar… @InfoNbpas @ABMSCert

Are ABMS’ lobbying tactics misleading politicians and the public? | Medical Economics

What the organization is doing may be legal, but is it ethical?

medicaleconomics.com
1
15
3
34
5,547
This 👇
National Board of Physicians and Surgeons
@InfoNbpas4 Nov 2025
📢 𝐈𝐧 𝐜𝐚𝐬𝐞 𝐲𝐨𝐮 𝐦𝐢𝐬𝐬𝐞𝐝 𝐢𝐭: Check out NBPAS President Dr. Paul Teirstein’s op-ed in The Wall Street Journal explaining how the current board certification monopoly is worsening the physician shortage — and why change is needed. @WSJ Read the full piece here: buff.ly/DX9FhNH
5
11
1,717
BREAKING NEWS: WSJ just published an op-ed by Dr. Paul Teirstein on how the current board certification monopoly is driving physicians out of medicine. It’s time for change! ⁦@WSJ⁩ ⁦@HHSGov⁩ ⁦@FTC⁩ ⁦@TheJusticeDept⁩ wsj.com/opinion/the-gatekeep…

Opinion | The Gatekeeper Driving Doctors From Medicine

The private American Board of Medical Specialties acts like a regulator, hamstringing physicians with endless fees, paperwork and testing.

wsj.com
5
41
3
146
21,191
Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis: @JACCJournals 🥸 on drug coated balloons. 👇👇👇
4
23
3
123
21,676
Congratulations to Dr Brian Jefferson and the team at Tristar HCA Hospital in Nashville, TN for performing the 1st two cases worldwide with the new Shockwave CS Guide Catheter! The two single arm cases were performed as part of the COSIRA II trial and the new guide catheter delivered improved performance and useability by being Shockwave's first guide catheter designed specifically for the coronary venous system. To learn more about the COSIRA-II trial and the participating sites visit  clinicaltrials.gov  ISI  bit.ly/3iEq7fC  Caution: Reducer System is an Investigational Device. Limited by U.S. and Canadian law to investigational use.
2
9
418
The FRACTURE IDE Trial aims to assess the safety and efficacy of a novel intravascular lithotripsy system by BOLT Medical in patients undergoing PCI for the treatment of coronary artery disease with severely calcified lesions. Dr. Brian K. Jefferson (@mobitz), a physician at TriStar Centennial Medical Center, and investigator with the @HCAhealthcare Research Institute, performed the first U.S. procedures, officially initiating enrollment at U.S. sites for the FRACTURE IDE trial. Learn more: clinicaltrials.gov/study/NCT… CAUTION: Investigational device. Limited by US law to investigational use only. Not available for sale.
1
3
15
1,375
* BREAKING* ABIM loses copyright infringement case against Dr. Jaime Salas-Rushford AND loses effort to seal opinion. Depositions, tactics, ABIM attorney insults, secret agreements: entire docket. All public now. medtees.com/content/SEALED%2… medtees.com/content/DNJ%20Se…
18
46
8
223
43,476
1/ Renal Denervation- which system works? The two main players in the space are ultrasound guided (@ReCorMedical Paradise) and radio frequency (@MedtronicCRDN Simplicity). When starting a new program how do you choose? Let’s review #RDN #CardioX #NephroX #NoCOI
7
40
2
151
26,619
Lots of (appropriate) renewed “buzz” about IVI 👁️with publication of recent 2024/2025 ESC and ACC/SCAI guidelines. If you’re not imaging pre-, intra-, and post-PCI: why not? If your Cath Lab doesn’t support IVI 👁️: why not?…
1
14
66
4,731
This year I am late in #my_4_slides on my most important takeaways from #CTO2025 Lots of great stuff and I will start with the intriguing #CTO #PCI techniques I will try in 2025. 1-HDR presentation by @realarainmd He explains it perfectly, his cases on X are enjoyable. In a very simple way 1-Stick the cap (a few mm) 2-Advance MC- pull wire while dripping contrast (prevent air trapping in the MC) 3-Inject slowly <0.5 cc 4-Analyze and decide next steps If intraplaque staining, nontip Fielder XT. If extraplaque, move down your algorithm (stick again or use other techniques) #cardioX #accfit
3
42
2
143
17,924
Replying to @VincentRK @chadinabhan @Rfonsi1
When MOC becomes necessary for maintaining licensure, the ballgame’s over and states will lose their autonomy to regulate physicians. Fortunately, the Supreme Court has already seen through @TheFSMB agenda for nationwide regulation of dentists drwes.blogspot.com/2018/08/f…
1
5
386
Replying to @CMichaelGibson
Been there, done that. Silly to think cardiologists can do a better job than cardiologists already have (like @InfoNbpas ). Anything else is corrupt. Prove me wrong.
3
1
19
1,530
Support @InfoNbpas
C. Michael Gibson MD
@CMichaelGibson2 Mar 2025
Should professional societies lead the creation of a new cardiovascular board or should it be spearheaded by a new group ?
41%Professional societies
24%New group
20%Use NBPAS
15%Show results
228 votes • Final results
8
684
Board system is broken....Request for an American Board of Cardiovascular Medicine denied—cardiology groups ‘deeply disappointed’ cardiovascularbusiness.com/t…

Request for an American Board of Cardiovascular Medicine denied—cardiology groups ‘deeply disappo...

The ACC, AHA, HFSA, HRS and SCAI all worked together to try and make the new board a reality. Though their proposal has been denied, the groups say they are not done fighting.

cardiovascularbusiness.com
3
13
1,100
This is such sad news. I think we all wanted @ACCinTouch to take over our certification in #cardiology & not leave to the ABMS. Cardiology is often a Department, not within a Division of Medicine. We need to separate to make this happen. 😢😢😢 #CardioTwitter
26
28
3
158
23,934
BREAKING The American Board of Medical Specialties (ABMS) has denied cardiologists request to create the American Board of Cardiovascular Medicine (ABCVM). cvboard.org/
32
31
5
124
51,697
Load more